HMI-S201

We estimated the prevalence and correlates of mild cognitive impairment (MCI) among middle-aged and older diverse Hispanics/Latinos.Middle-aged and older diverse Hispanics/Latinos enrolled (n = 6377; 50-86 years) in this multisite prospective cohort study were evaluated for MCI using the National Institute on Aging-Alzheimer’s Association diagnostic criteria.

HMI Protein Vector (Human) (pPM-C-His)

PV084028 500 ng Ask for price

HMI 3'UTR Luciferase Stable Cell Line

TU010007 1.0 ml
EUR 2799.6

HMI sgRNA CRISPR Lentivector (Human) (Target 1)

K0974302 1.0 ug DNA
EUR 184.8

HMI sgRNA CRISPR Lentivector (Human) (Target 2)

K0974303 1.0 ug DNA
EUR 184.8

HMI sgRNA CRISPR Lentivector (Human) (Target 3)

K0974304 1.0 ug DNA
EUR 184.8

HMI Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV728375 1.0 ug DNA Ask for price

HMI Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV728379 1.0 ug DNA Ask for price

HMI Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728380 1.0 ug DNA Ask for price

HMI sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0974305 3 x 1.0 ug
EUR 451.2

HMI sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0974306 1.0 ug DNA
EUR 200.4

HMI sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0974307 1.0 ug DNA
EUR 200.4

HMI sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0974308 1.0 ug DNA
EUR 200.4

HMI Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV728376 1.0 ug DNA Ask for price

HMI Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV728377 1.0 ug DNA Ask for price

HMI Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV728378 1.0 ug DNA Ask for price

S18-000003

555361 25.0mg
EUR 350

S18-000003

T16832-10mg 10mg Ask for price
Description: S18-000003

S18-000003

T16832-1g 1g Ask for price
Description: S18-000003

S18-000003

T16832-1mg 1mg Ask for price
Description: S18-000003

S18-000003

T16832-50mg 50mg Ask for price
Description: S18-000003

S18-000003

T16832-5mg 5mg Ask for price
Description: S18-000003

Gynkotek 320 340S 160 170S Lamp - EACH

LMP2016 EACH
EUR 591.3

S-23906-1

T34474-10mg 10mg Ask for price
Description: S-23906-1

S-23906-1

T34474-1g 1g Ask for price
Description: S-23906-1

S-23906-1

T34474-1mg 1mg Ask for price
Description: S-23906-1

S-23906-1

T34474-50mg 50mg Ask for price
Description: S-23906-1

S-23906-1

T34474-5mg 5mg Ask for price
Description: S-23906-1

S116836

T24751-10mg 10mg Ask for price
Description: S116836

S116836

T24751-1g 1g Ask for price
Description: S116836

S116836

T24751-1mg 1mg Ask for price
Description: S116836

S116836

T24751-50mg 50mg Ask for price
Description: S116836

S116836

T24751-5mg 5mg Ask for price
Description: S116836

S07-2008

T62373-10mg 10mg Ask for price
Description: S07-2008

S07-2008

T62373-1g 1g Ask for price
Description: S07-2008

S07-2008

T62373-1mg 1mg Ask for price
Description: S07-2008

S07-2008

T62373-50mg 50mg Ask for price
Description: S07-2008

S07-2008

T62373-5mg 5mg Ask for price
Description: S07-2008

S-777469

T62132-10mg 10mg Ask for price
Description: S-777469

S-777469

T62132-1g 1g Ask for price
Description: S-777469

S-777469

T62132-1mg 1mg Ask for price
Description: S-777469

S-777469

T62132-50mg 50mg Ask for price
Description: S-777469

S-777469

T62132-5mg 5mg Ask for price
Description: S-777469

S07-2010

T61485-10mg 10mg Ask for price
Description: S07-2010

S07-2010

T61485-1g 1g Ask for price
Description: S07-2010

S07-2010

T61485-1mg 1mg Ask for price
Description: S07-2010

S07-2010

T61485-50mg 50mg Ask for price
Description: S07-2010

S07-2010

T61485-5mg 5mg Ask for price
Description: S07-2010

S07-2009

T61003-10mg 10mg Ask for price
Description: S07-2009

S07-2009

T61003-1g 1g Ask for price
Description: S07-2009

S07-2009

T61003-1mg 1mg Ask for price
Description: S07-2009

S07-2009

T61003-50mg 50mg Ask for price
Description: S07-2009

S07-2009

T61003-5mg 5mg Ask for price
Description: S07-2009

S07-2001

T61033-10mg 10mg Ask for price
Description: S07-2001

S07-2001

T61033-1g 1g Ask for price
Description: S07-2001

S07-2001

T61033-1mg 1mg Ask for price
Description: S07-2001

S07-2001

T61033-50mg 50mg Ask for price
Description: S07-2001

S07-2001

T61033-5mg 5mg Ask for price
Description: S07-2001

Compound S006-0019

T127578-10mg 10mg Ask for price
Description: Compound S006-0019

Compound S006-0019

T127578-1g 1g Ask for price
Description: Compound S006-0019

Compound S006-0019

T127578-1mg 1mg Ask for price
Description: Compound S006-0019

Compound S006-0019

T127578-50mg 50mg Ask for price
Description: Compound S006-0019

Compound S006-0019

T127578-5mg 5mg Ask for price
Description: Compound S006-0019

Phospho-PAK1/2/3-S144/S141/S139 Rabbit mAb

AP1158 20μL
EUR 247
Description: This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2010]

Anti-Phospho-Rsk-1/2/3/4 (S221/227/S218/232) antibody

STJ90596 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-Rsk-1/2/3/4 (S221/227/S218/232).

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D)

CSB-EP846108HU(F2)(M1) 7300 mg Ask for price

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D)

RPC27342-100ug 100ug
EUR 818.4

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D)

RPC27342-1mg 1mg
EUR 3079.4

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D)

RPC27342-20ug 20ug
EUR 519.2

PAK4 + PAK5 + PAK6 (S474 + S560 + S602) Rabbit mAb

14252 100ul
EUR 339

TSC2 (Center S1385/S1386) Rabbit pAb

E2617227 100ul
EUR 225
Description: Available in various conjugation types.

ERBB2 (C-term S1050/S1051) Rabbit pAb

E2618727 100ul
EUR 225
Description: Available in various conjugation types.

TSC2 (Center S1418/S1420) Rabbit pAb

E2614517 100ul
EUR 225
Description: Available in various conjugation types.

S07-2005 (racemic)

T61511-10mg 10mg Ask for price
Description: S07-2005 (racemic)

S07-2005 (racemic)

T61511-1g 1g Ask for price
Description: S07-2005 (racemic)

S07-2005 (racemic)

T61511-1mg 1mg Ask for price
Description: S07-2005 (racemic)

S07-2005 (racemic)

T61511-50mg 50mg Ask for price
Description: S07-2005 (racemic)

S07-2005 (racemic)

T61511-5mg 5mg Ask for price
Description: S07-2005 (racemic)

Influenza A Virus H5N1 (A/Cambodia/S1211394/2008) HA protein, His Tag

E40VAG177 20ug
EUR 495

Recombinant Human CUGBP Elav-like family member 1(CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D,L408A,P409A)

CSB-EP846108HU(F2)(M3) 7302 mg Ask for price

Recombinant Human CUGBP Elav-like family member 1(CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D), partial

CSB-EP846108HU1(F2)(M2) 7310 mg Ask for price

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D,L408A,P409A)

RPC27343-100ug 100ug
EUR 818.4

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D,L408A,P409A)

RPC27343-1mg 1mg
EUR 3079.4

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D,L408A,P409A)

RPC27343-20ug 20ug
EUR 519.2

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D) ,partial

RPC27344-100ug 100ug
EUR 818.4

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D) ,partial

RPC27344-1mg 1mg
EUR 3079.4

Recombinant Human CUGBP Elav-like family member 1 (CELF1) (T173E,S178D,S285D,S288D,S295D,S296D,S298D) ,partial

RPC27344-20ug 20ug
EUR 519.2

Phospho- PAK1/2/3 (S144+ S141+ S139) Antibody

ABD2948 100 ug
EUR 525.6

S31-201

202541 25.0mg
EUR 150

S-49076

206484 50.0mg
EUR 450

S63845

406849 1.0mg
EUR 90

S-55746

407949 5.0mg
EUR 300

S32826

562163 5.0mg
EUR 340

S18986

526937 5.0mg
EUR 260

S26131

532617 5.0mg
EUR 90

S26948

B7471-10 10 mg
EUR 271
Description: PPARγ agonist

S26948

B7471-50 50 mg
EUR 1108
Description: PPARγ agonist

S63845

B1819-250 each
EUR 189.6

S63845

A8737-1 1 mg
EUR 72
Description: MCL1 inhibitor

S63845

A8737-10 10 mg
EUR 400
Description: MCL1 inhibitor

S63845

A8737-25 25 mg
EUR 800
Description: MCL1 inhibitor

S63845

A8737-5 5 mg
EUR 240
Description: MCL1 inhibitor

S18886

C5387-10 10 mg
EUR 82
Description: Potent thromboxane A2 (TP) inhibitor

S18886

C5387-5 5 mg
EUR 54
Description: Potent thromboxane A2 (TP) inhibitor

S-24795

574419 10.0mg
EUR 290

S-25585

574420 10.0mg
EUR 375

S14161

GL4789-1 1
EUR 116.1

S14161

GL4789-1MG 1 mg
EUR 171.6

S14161

GL4789-5 5
EUR 346.1

S14161

GL4789-5MG 5 mg
EUR 440.4

S23757

T26171-10mg 10mg Ask for price
Description: S23757

S23757

T26171-1g 1g Ask for price
Description: S23757

S23757

T26171-1mg 1mg Ask for price
Description: S23757

S23757

T26171-50mg 50mg Ask for price
Description: S23757

S23757

T26171-5mg 5mg Ask for price
Description: S23757

S26131

T16834-10mg 10mg Ask for price
Description: S26131

S26131

T16834-1g 1g Ask for price
Description: S26131

S26131

T16834-1mg 1mg Ask for price
Description: S26131

S26131

T16834-50mg 50mg Ask for price
Description: S26131

S26131

T16834-5mg 5mg Ask for price
Description: S26131

S24014

T34475-10mg 10mg Ask for price
Description: S24014

S24014

T34475-1g 1g Ask for price
Description: S24014

S24014

T34475-1mg 1mg Ask for price
Description: S24014

S24014

T34475-50mg 50mg Ask for price
Description: S24014

S24014

T34475-5mg 5mg Ask for price
Description: S24014

S24773

T34476-10mg 10mg Ask for price
Description: S24773

S24773

T34476-1g 1g Ask for price
Description: S24773

S24773

T34476-1mg 1mg Ask for price
Description: S24773

S24773

T34476-50mg 50mg Ask for price
Description: S24773

S24773

T34476-5mg 5mg Ask for price
Description: S24773

S26284

T34477-10mg 10mg Ask for price
Description: S26284

S26284

T34477-1g 1g Ask for price
Description: S26284

S26284

T34477-1mg 1mg Ask for price
Description: S26284

S26284

T34477-50mg 50mg Ask for price
Description: S26284

S26284

T34477-5mg 5mg Ask for price
Description: S26284

S-73362

T34480-10mg 10mg Ask for price
Description: S-73362

S-73362

T34480-1g 1g Ask for price
Description: S-73362

S-73362

T34480-1mg 1mg Ask for price
Description: S-73362

S-73362

T34480-50mg 50mg Ask for price
Description: S-73362

S-73362

T34480-5mg 5mg Ask for price
Description: S-73362

S49076

T3274-10mg 10mg Ask for price
Description: S49076

S49076

T3274-1g 1g Ask for price
Description: S49076

S49076

T3274-1mg 1mg Ask for price
Description: S49076

S49076

T3274-50mg 50mg Ask for price
Description: S49076

S49076

T3274-5mg 5mg Ask for price
Description: S49076

S07662

T24750-10mg 10mg Ask for price
Description: S07662

S07662

T24750-1g 1g Ask for price
Description: S07662

S07662

T24750-1mg 1mg Ask for price
Description: S07662

S07662

T24750-50mg 50mg Ask for price
Description: S07662

S07662

T24750-5mg 5mg Ask for price
Description: S07662

S26948

T23304-50mg 50mg Ask for price
Description: S26948

S26948

T23304-5mg 5mg Ask for price
Description: S26948

S26948

T23304-10mg 10mg Ask for price
Description: S26948

S26948

T23304-1g 1g Ask for price
Description: S26948

S26948

T23304-1mg 1mg Ask for price
Description: S26948

S-14671

T28641-10mg 10mg Ask for price
Description: S-14671

The overall MCI prevalence was 9.8%, which varied between Hispanic/Latino groups. Older age, high cardiovascular disease (CVD) risk, and elevated depressive symptoms were significant correlates of MCI prevalence. Apolipoprotein E4 (APOE) and APOE2 were not significantly associated with MCI.MCI prevalence varied among Hispanic/Latino backgrounds, but not as widely as reported in the previous studies.

CVD risk and depressive symptoms were associated with increased MCI, whereas APOE4 was not, suggesting alternative etiologies for MCI among diverse Hispanics/Latinos. Our findings suggest that mitigating CVD risk factors may offer important pathways to understanding and reducing MCI and possibly dementia among diverse Hispanics/Latinos.